EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP.

Autor: Janssens, A, Snauwaert, S, Bron, D, Berneman, Z, Offner, F, Van Bogaert, C, De Beleyr, B, Smet, A, Nielsen, L, Wapenaar, R, André, M
Zdroj: Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-3, 3p
Databáze: Complementary Index
Externí odkaz: